With Monday's fall, the stock is now down 37% from its 52-week high level of ₹18,700.
Here are five stats that have highlighted an otherwise forgettable year for its shareholders:
First, shares are down 34% so far in 2025. This is the worst drop in a calendar year for Dixon since 2018, which was its first full year of listing, when the stock fell 50%. The only other drop it has had in a calendar year is the 29% fall in 2022.
| Year | Returns |
| 2018 | -51% |
| 2019 | 84% |
| 2020 | 254% |
| 2021 | 105% |
| 2022 | -29% |
| 2023 | 68% |
| 2024 | 173% |
| 2025 (YTD) | -34% |
Second, the stock is down 19% so far in December. This is the worst month that the stock has had since January 2023, when the stock fell 31%.
Third, this is also the first time in its trading history that the stock has delivered negative returns for five months in a row. The previous highest is only three months on multiple instances in the past.
| Month | Returns |
| December 2025 | -19% |
| November 2025 | -6% |
| October 2025 | -5% |
| September 2025 | -3% |
| August 2025 | -1% |
Fourth, 2025 also mirrors 2018, when the stock had delivered negative returns in 9 out of 12 months of the year. In 2024, the stock had gained in 11 out of the 12 months.
and lastly, the stock now trades close to its second-lowest price target of ₹11,563, from Morgan Stanley. The lowest is ₹9,085 by Phillip Securities.
Looking forward to the month of January, the last four years have seen Dixon shares deliver negative returns in the first month of the year, with an average decline of 19%, including a 31% drop in January 2023 and 16% in January this year.
| January Years | Returns |
| 2025 | -17% |
| 2024 | -9% |
| 2023 | -31% |
| 2022 | -20% |
| 2021 | 5% |
| 2020 | 23% |
| 2019 | 10% |
In its note earlier this month, Morgan Stanley had highlighted that the extension of the IT Hardware import norms are leading to growth uncertainty as other brands can continue to import under requisite licenses and disclosures.
The brokerage expects IT hardware to contribute 7% to Dixon's revenue in financial year 2030 but warns that the company may face challenges to meet its guidance in the coming years and that favourable import norms could pose a downside risk to its estimates.
Most of the street though, remains bullish on Dixon's prospects, with 27 out of the 35 analysts covering the stock having a "buy" rating on the stock, two say "hold", while six others have a "sell" rating. The consensus estimate of analyst price targets currently imply a potential upside of 51% for the stock from current levels.
/images/ppid_59c68470-image-176705253288796920.webp)

/images/ppid_59c68470-image-17669875305852820.webp)
/images/ppid_59c68470-image-176698253242143418.webp)
/images/ppid_59c68470-image-176699006419459192.webp)
/images/ppid_59c68470-image-176698260311992296.webp)

/images/ppid_59c68470-image-176697503740925196.webp)
/images/ppid_59c68470-image-1767032562118860.webp)
/images/ppid_59c68470-image-176698012154472675.webp)
/images/ppid_59c68470-image-176700502637782973.webp)
/images/ppid_59c68470-image-176697260193239764.webp)